$QURE SEC Filings

Filed On	Filing
02 Nov 2026	8-K: Regulation FD Disclosure; Other Events Date of Report (Date of earliest event reported): October 30, 2026
16 Oct 2026	SCHEDULE 13G/A
29 Sep 2026	8-K: Regulation FD Disclosure Ashley – Huntington’s Disease Community Advocate Phase I/II ifezuntirgene inilparvovec (AMT-130) Huntington’s Disease Program Update September 29, 2026
02 Sep 2026	8-K: Regulation FD Disclosure
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G
29 Jul 2026	S-8
29 Jul 2026	10-Q
29 Jul 2026	8-K: Results of Operations and Financial Condition
20 Jul 2026	SCHEDULE 13G/A
16 Jul 2026	SCHEDULE 13G
07 Jul 2026	Form 4: Kapusta Matthew C, Director Received 21,082 shares by exercise or conversion ($409K) · Sold 21,082 shares ($952K)
02 Jul 2026	Form 4: Abi-Saab Walid, Chief Medical Officer Received 10,000 shares by exercise or conversion ($55.9K) · Sold 30,000 shares ($1.39M)
02 Jul 2026	Form 4: Kaye Jack, Director Received 21,167 shares by exercise or conversion ($496K) · Sold 21,167 shares ($983K)
02 Jul 2026	144
30 Jun 2026	Form 4: Abi-Saab Walid, Chief Medical Officer Sold 1,434 shares ($67.2K)
30 Jun 2026	144
30 Jun 2026	144
26 Jun 2026	Form 4: Kapusta Matthew C, Director Received 4,128 shares by exercise or conversion ($131K) · Sold 6,696 shares ($335K) · Received 28,716 shares by exercise or conversion ($911K) · 1 more
26 Jun 2026	144

Comments